These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20003144)

  • 21. Not without my permission: parents' willingness to permit use of newborn screening samples for research.
    Tarini BA; Goldenberg A; Singer D; Clark SJ; Butchart A; Davis MM
    Public Health Genomics; 2010; 13(3):125-30. PubMed ID: 19602864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First experience with a fully automated extraction system for simultaneous on-line direct tandem mass spectrometric analysis of amino acids and (acyl-)carnitines in a newborn screening setting.
    Fingerhut R; Silva Polanco ML; Silva Arevalo Gde J; Swiderska MA
    Rapid Commun Mass Spectrom; 2014 Apr; 28(8):965-73. PubMed ID: 24623702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Storage policies and use of the Danish Newborn Screening Biobank.
    Nørgaard-Pedersen B; Hougaard DM
    J Inherit Metab Dis; 2007 Aug; 30(4):530-6. PubMed ID: 17632694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiling of archived dried blood spot samples from the Danish Neonatal Screening Biobank.
    Grauholm J; Khoo SK; Nickolov RZ; Poulsen JB; Bækvad-Hansen M; Hansen CS; Hougaard DM; Hollegaard MV
    Mol Genet Metab; 2015 Nov; 116(3):119-24. PubMed ID: 26212339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mass spectrometry in clinical chemistry: the case of newborn screening.
    la Marca G
    J Pharm Biomed Anal; 2014 Dec; 101():174-82. PubMed ID: 24844843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of newborn screening connect (NBS connect): a self-reported patient registry and its role in improvement of care for patients with inherited metabolic disorders.
    Osara Y; Coakley K; Devarajan A; Singh RH
    Orphanet J Rare Dis; 2017 Jul; 12(1):132. PubMed ID: 28724394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Committee report: Considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening.
    Therrell BL; Hannon WH; Bailey DB; Goldman EB; Monaco J; Norgaard-Pedersen B; Terry SF; Johnson A; Howell RR
    Genet Med; 2011 Jul; 13(7):621-4. PubMed ID: 21602691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concerns of newborn blood screening advisory committee members regarding storage and use of residual newborn screening blood spots.
    Rothwell EW; Anderson RA; Burbank MJ; Goldenberg AJ; Lewis MH; Stark LA; Wong B; Botkin JR
    Am J Public Health; 2011 Nov; 101(11):2111-6. PubMed ID: 21330580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Mathematical Algorithm for Dried Blood Spot Quality Assessment and Results concerning Quality from a Newborn Screening Program.
    Oprea OR; Barabas AZ; Manescu IB; Dobreanu M
    J Appl Lab Med; 2024 May; 9(3):512-525. PubMed ID: 38384160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary investigation of the use of newborn dried blood spots for screening pyridoxine-dependent epilepsy by LC-MS/MS.
    Jung S; Tran NT; Gospe SM; Hahn SH
    Mol Genet Metab; 2013 Nov; 110(3):237-40. PubMed ID: 23953072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of genomic DNA in dried blood spots stored on filter paper.
    Chaisomchit S; Wichajarn R; Janejai N; Chareonsiriwatana W
    Southeast Asian J Trop Med Public Health; 2005 Jan; 36(1):270-3. PubMed ID: 15906682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A computer vision approach to the assessment of dried blood spot size and quality in newborn screening.
    Flynn N; Moat SJ; Hogg SL
    Clin Chim Acta; 2023 Jul; 547():117418. PubMed ID: 37276944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State laws regarding the retention and use of residual newborn screening blood samples.
    Lewis MH; Goldenberg A; Anderson R; Rothwell E; Botkin J
    Pediatrics; 2011 Apr; 127(4):703-12. PubMed ID: 21444595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary proficiency testing results for succinylacetone in dried blood spots for newborn screening for tyrosinemia type I.
    Adam BW; Lim TH; Hall EM; Hannon WH
    Clin Chem; 2009 Dec; 55(12):2207-13. PubMed ID: 19850631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contamination of dried blood spots - an underestimated risk in newborn screening.
    Winter T; Lange A; Hannemann A; Nauck M; Müller C
    Clin Chem Lab Med; 2018 Jan; 56(2):278-284. PubMed ID: 28763295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatricians' attitudes toward expanding newborn screening.
    Acharya K; Ackerman PD; Ross LF
    Pediatrics; 2005 Oct; 116(4):e476-84. PubMed ID: 16199673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inborn errors of metabolism and expanded newborn screening: review and update.
    Mak CM; Lee HC; Chan AY; Lam CW
    Crit Rev Clin Lab Sci; 2013 Nov; 50(6):142-62. PubMed ID: 24295058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up data collection and use in state newborn screening programs.
    Hoff T; Ayoob M; Therrell BL
    Arch Pediatr Adolesc Med; 2007 Oct; 161(10):994-1000. PubMed ID: 17909144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility of neonatal dried blood spot retrieval amid evolving state policies (2009-2010): a Children's Oncology Group study.
    Linabery AM; Slater ME; Spector LG; Olshan AF; Stork SK; Roesler MA; Reaman GH; Ross JA
    Paediatr Perinat Epidemiol; 2011 Nov; 25(6):549-58. PubMed ID: 21980944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Information and consent for newborn screening: practices and attitudes of service providers.
    Kerruish NJ; Webster D; Dickson N
    J Med Ethics; 2008 Sep; 34(9):648-52. PubMed ID: 18757632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.